Daily Newsletter 20 Jul, 2011 Morning Glance Equity Research Desk Market Summary
The market closed on a negative note on Tuesday. The overall market breadth
was positive, around 57.2% of shares advanced on BSE and 59.4% of shares
advanced on NSE. Out of the total 3,004 shares traded at BSE, 1,652 advanced,
1,219 declined, while 133 remained unchanged. After a lackluster morning trade,
benchmark indices, taking cues from the positive European markets, spiked up in
the afternoon and ended with decent gains. Auto stocks continued their
underperformance. Key European markets were trading with gains ranging from
0.5% to 1.5%, buoyed by solid results from Novartis AG and gains in shares of
technology companies. US stock futures were up about two third of a percent
ahead of data on June housing starts and building permits. BSE Consumer
Durable and IT indices gained the most among the sectoral indices, putting on
1.4% and 1.2% respectively while Auto and Power indices lost 0.4% and 0.3%
At the close, the benchmark 30-share index, BSE Sensex gained 146.83 points or
0.79% at 18,653.87 with 24 components registering rise. Meanwhile, the broad
*7.35 A.M Today
based NSE Nifty climbed by 46.50 or 0.84% at 5,613.55 with 44 components
Delivery Delivery Statistics Nifty Most Delivered Gainers in the 30-share index were D L F (2.09%), Sterlite Industries (India)
(1.77%), Tata Power Company (1.62%), State Bank Of India (1.59%), Infosys
Technologies (1.45%), and Reliance Industries (1.39%). However, Tata
Motors (3.16%), Hero Honda Motors (1.22%), Maruti Suzuki India (0.79%), H D
F C Bank (0.70%), Hindustan Unilever (0.42%), and Oil & Natural Gas
Corporation (0.09%) were the biggest losers in the Sensex.
Nifty Least Delivered RELCAPITAL 637190
Strong profits and a bipartisan plan to lift the U.S. debt limit drove a US stock
market rebound Tuesday. The Dow Jones industrial average gained 202.26
points, or 1.63%, to close at 12,587.42. The Nasdaq gained 61.41 points, or Trade Statistics Board Meeting Total 3004
IRB Infrastructure Developers Limited Result
Inst. Activity FIIs (Rs cr) Source : SEBI Open Interest(Rs. Cr) 89,591 MFs (Rs cr) 18-Jul Indicators Change (pts) 10,775 12,014 3,179,509 89,591 Daily Newsletter 20 Jul, 2011 Morning Glance Equity Research Desk Junior Nifty Delivery Statistics for 19th Jul 2011
ABB wins USD 15 mn water order in Saudi Arabia Traded Qty Delivery
Power and automation technology group ABB has won an order worth about
USD 15 mil ion from Japanese pump manufacturer, Torishima Pump, to provide
a turnkey electrical control and instrumentation solution for a new pumping
station under construction in Saudi Arabia.
NIIT Tech Q1 cons profit up marginally
NIIT Technologies has posted a consolidated net profit of Rs 412 million for the
quarter ended June 30, 2011 as compared to Rs 408 mil ion for the quarter
ended June 30, 2010, representing increase of 0.8%. Total Income has
increased from Rs 2,914 mil ion for the quarter ended June 30, 2010 to Rs 3,288
million for the quarter ended June 30, 2011, representing increase of 12.83%
Supreme Petrochem FY11 profit jumps 45% Supreme Petrochem (SPL), a styrenics major and the largest polystyrene Derivatives Watch
producer in India has posted a net profit of Rs 876.9 million for the year ended June 30, 2011 as compared to Rs 604.7 mil ion for the year ended June 30,
Nifty OI PCR at 1.20 as against 1.25 onTuesday
2010 representing rise of 45.01%. Net revenues for the year 10-11 stood at Rs
Nifty up 0.84%; Futures OI up 0.93%
19.43 billion as compared to Rs 16.11 billion in the preceding year.
Nifty Jul. futures trading at 5.45 points Premium Cadila Q1 cons net grows 15.6% Commodity Update
Pharmaceutical company Cadila Healthcare has posted growth of 15.58% in its
consolidated net profit at Rs 2.30 billion for the quarter ended June 30, 2011 as
Asian stocks rose, with the regional benchmark index set to
against Rs 1.99 billion for the corresponding quarter a year ago. Total income of
close at its highest level in a week, on optimism U.S. lawmakers
the company on consolidated basis has increased by 10.11% at Rs 12.52 bil ion
wil reach an agreement to cut the budget deficit and after Apple
for June quarter as against Rs 11.37 billion for the corresponding quarter a year
Inc.`s profit topped estimates, boosting the earnings outlook for
exporters. Japanese benchmark index Nikkei 225 rose 141.34
points, or 1.43%, to trade at 10,031.10. Hong Kong`s Hang
Sun Pharma gets USFDA nod for Uroxatral ER
Seng index advanced by 170.49 points, or 0.78%, at 22,072.90.
Sun Pharmaceuticals Industries announced that USFDA has granted its
South Korea`s Kospi index increased 24.37 points, or 1.14% to
subsidiary an approval for its abbreviated new drug Application (ANDA) to
market a generic version of Uroxatral ER, alfuzosin hydrochloride extended
release tablets. Sun Pharma, being the first to file an ANDA for generic version
Oil prices reversed direction again Tuesday, rising 2% as
of Uroxatral ER with a para IV certification, received a 180 days marketing
traders took their cues from the dol ar and stock markets. Brent
crude, which is used to price many international oil varieties,
gained USD 1.01 to settle at USD 117.06 a barrel on the ICE
Shilpa Medicare acquires controlling stake in Nu Therapeutics
Shilpa Medicare had invested in Nu Therapeutics (P), (NU) initially in the last
year and now acquired controlling stake. NU is established by the Technocrats
In the commodity space, MCXCOMDEX was up on Tuesday
for manufacturing of oral fast dissolving thin strip dosage jointly with others.
0.77% to 3,538.44 points, MCX Metal index was up by 0.31% to
4,738.44 points and MCX Energy index was up by 1.04% to
Thomas Cook to offer training course to TIRUN Travel
Thomas Cook (India), the integrated travel and travel related financial services
company in India, has signed a one-of-its kind agreement with TIRUN Travel
Bullion: Gold August 11 contract was down by 0.20% to Rs
Marketing to offer a unique online training course certified by Royal Caribbean
23,181 per 10 grams, GoldM August 11 contract was down by
0.20% to Rs 23,184 per 10 grams, Gold guinea July 11 contract
was down by 0.16% to Rs 18,570 per 8 grams and Gold Petal
Indowind Energy inks power sale pact with Apollo Hospitals
July 11 contract was down by 0.17% to Rs 2,328 per gram.
Indowind Energy has successfully completed the power sale agreement with
Silver September 11 contract was up by 0.04% to Rs 59,895 per
Apollo Hospitals Enterprise, for supply of 10 million units per annum under
kg, SilverM August 11 contract was up by 0.03% to Rs 59,901
Group Captive` scheme through its subsidiary Indowind Power. This strategic
per kg and SilverMIC August 11 contract was up by 0.02% to Rs
tie-up shall give long term benefit to the companies. The stock had
59,907 per kg. Metals: Lead July 11 contract was up by 0.91%
outperformed the market over the past one month till Jul. 18, 2011, rising
69.52% compared with the Sensex`s 3.56% rise.
Major BSE Bulk Deals Scrip Name Client Name Deal Type Major NSE Bulk Deals Scrip Name Client Name Deal Type Daily Newsletter 20 Jul, 2011 Morning Glance Equity Research Desk Disclaimer: This report is for the personal information of the authorized recipient and does not construe to be any investment, legal or taxation advice to you. SPA Securities Limited (hereinafter referred as SPA) is not soliciting any action based upon it. This report is not for public distribution and has been furnished to you solely for your information and should not be reproduced or redistributed to any other person in any form. This document is provided for assistance only and is not intended to be and must not alone be taken as the basis for an investment decision. The intent of this document is not in recommendary nature. The views expressed are those of analyst and the Company may or may not subscribe to all the views expressed therein The report is based upon information that we consider reliable, but we do not represent that it is accurate or complete, and it should not be relied upon such. SPA or any of its affiliates or employees shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. Neither the Firm, not its directors, employees, agents or representatives shall be liable for any damages whether direct or indirect, incidental, special or consequential including lost revenue or lost profits that may arise from or in connection with the use of the information. SPA or any of its affiliates or employees do not provide, at any time, any express or implied warranty of any kind, regarding any matter pertaining to this report, including without limitation the implied warranties of merchantability, fitness for a particular purpose, and non-infringement. The recipients of this report should rely on their own investigations. SPA and/or its affiliates and/or employees may have interests/ positions, financial or otherwise in the securities mentioned in this report. SPA has incorporated a Disclosure of Interest Statement in this document. This should, however, not be treated as endorsement of the views expressed in the report. This information is subject to change without any prior notice. SPA reserves the right to make modifications and alternations to this statement as may be required from time to time. Nevertheless, SPA is committed to providing independent and transparent recommendations to its clients, and would be happy to provide information in response to specific client queries. Research SPA Securities Limited SPA House, Nyay Sagar, Near Gurunanak Hospital, Bandra (E), Mumbai - 400051, Tel. No. : +91-22-4289 5000
For More Information Visit Us At www.spasecurities.com
SPA Securities Ltd.
Member of NCDEX & MCX. NCDEX TMID- LTD.
Direct Broker for Life and General Insurance DP – CDSL
DISCIPLINA: QUIMICA FARMACEUTICA PLANO DE ENSINO OBJETIVOS: • Reconhecer os fármacos de origem sintética e semi-sintética, constantes das últimas edições de farmacopéias e outros códigos farmacêuticos. • Aplicar conhecimentos visando a obtenção de fármacos e seus análogos. • Identificar as relações estruturais e atividades farmacológicas existentes nas as clas
Myria Christophini Selected Exhibitions 2011: Bealtainne, The Glue Factory, Glasgow (30 April-14 May 2011). 2010: Half-knowledge/half., Grace and Clark Fyfe Gallery, Glasgow(12-28 2007: If it is to be, The BRIDGE Gallery, London (07-12 September 2007). 2007: Out of Nothing, Canterbury Environment Centre, Canterbury(01-10 May 2005: Transmission: Laurence Rathsack, Liz B